Full Text View
Tabular View
Study Results
Related Studies
Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study, Safety, Tolerability and Immunogenicity
This study has been terminated.
( Issues with CTM stability. )
Study NCT00772954   Information provided by Sanofi

First Received on October 10, 2008.   Last Updated on April 19, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Clostridium Difficile Infection
Clostridium Difficile Diarrhea
Additional conditions recognized in this trial
Clostridium Infections
Diarrhea
More general conditions related to this trial
Bacterial Infections
Gram-Positive Bacterial Infections
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
Vaccine diluent buffer
Sponsors listed in this trial
Sanofi


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services